Benedicte Stavik Selected Research

Persistent Organic Pollutants

1/2010

Natural mixtures of persistent organic pollutants (POP) increase weight gain, advance puberty, and induce changes in gene expression associated with steroid hormones and obesity in female zebrafish.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benedicte Stavik Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 08/2022 - 11/2010
12	Neoplasms (Cancer) 08/2022 - 11/2010
4	Thrombosis (Thrombus) 01/2020 - 07/2017
2	Inflammation (Inflammations) 01/2020 - 01/2017
2	Hypoxia (Hypoxemia) 09/2017 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 07/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 08/2011 - 11/2010
2	Weight Gain 04/2011 - 01/2010
2	Obesity 04/2011 - 01/2010
1	Hemorrhage 12/2021
1	Disease Progression 01/2020
1	Carotid Stenosis (Carotid Artery Stenosis) 07/2017
1	Ischemic Stroke 07/2017
1	Carotid Artery Diseases 07/2017
1	Type 2 Diabetes Mellitus (MODY) 10/2016
1	Atherosclerosis 01/2016
1	Body Weight (Weight, Body) 04/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2010

Drug/Important Bio-Agent (IBA)

13	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2019 - 06/2010
7	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
4	Thromboplastin (Tissue Factor)IBA 09/2017 - 08/2011
4	Hormones (Hormone)IBA 01/2017 - 01/2010
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2016
3	Protein Isoforms (Isoforms)IBA 01/2013 - 08/2011
2	Factor V (Coagulation Factor V)IBA 08/2022 - 01/2020
2	Blood Coagulation Factors (Coagulation Factor)IBA 08/2022 - 09/2017
2	Hemostatics (Antihemorrhagics)IBA 08/2022 - 08/2011
2	Estrogens (Estrogen)FDA Link 08/2022 - 01/2017
2	Estrogen ReceptorsIBA 08/2022 - 01/2017
2	Biological ProductsIBA 01/2020 - 01/2013
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 09/2017 - 01/2016
2	CytokinesIBA 01/2017 - 10/2016
2	Insulin (Novolin)FDA Link 10/2016 - 04/2011
1	Factor VII (Proconvertin)IBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2016
1	LipidsIBA 01/2016
1	Thrombin FDA Link 01/2016
1	CoagulantsIBA 01/2016
1	Syndecan-3IBA 01/2015
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 07/2014
1	Heparin (Liquaemin)FDA LinkGeneric 01/2013
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2013
1	Complementary DNA (cDNA)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	Tyrosine (L-Tyrosine)FDA Link 08/2011
1	Endocrine DisruptorsIBA 04/2011
1	Death Domain ReceptorsIBA 11/2010
1	SteroidsIBA 01/2010
1	Persistent Organic PollutantsIBA 01/2010

Therapy/Procedure

1	Carotid Endarterectomy 07/2017